LYTIR

Insider · SEC Form 4 · Former 10% Owner

Cormorant Asset Management, LP

In the 12 months to Nov 19, 2026, on the open market: sold $1.7M of CRBP. Filed 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. CRBPSold: Corbus Pharmaceuticals Holdings, Inc. Oct 29, 2026 425,000 shares filed Nov 2, 2026 1,919,971 shares held indirectly after, as filed filing $1.7M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. CRBPCormorant Asset Management, LP filed Nov 2, 2026 Schedule 13G/A passive 1,500,000 shares issuer: Corbus Pharmaceuticals Holdings, Inc. filing 7.76%
  2. IBIOCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 5,117,481 shares issuer: iBio, Inc. filing 9.99%
  3. QNCXCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G passive 108,029 shares issuer: Quince Therapeutics, Inc. filing 9.99%
  4. DRUGCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 900,000 shares issuer: Bright Minds Biosciences Inc. filing 9.17%
  5. EYPTCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 7,000,000 shares issuer: EyePoint, Inc. filing 8.35%
  6. ANLCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 3,978,229 shares issuer: Adlai Nortye Ltd. filing 6.77%
  7. CABACormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 10,000,000 shares issuer: Cabaletta Bio, Inc. filing 5.95%
  8. RAPPCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 2,657,521 shares issuer: Rapport Therapeutics, Inc. filing 5.56%
  9. BIOACormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 2,390,605 shares issuer: BioAge Labs, Inc. filing 5.38%
  10. MLTXCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 3,205,433 shares issuer: MoonLake Immunotherapeutics filing 4.35%
  11. RLYBCormorant Asset Management, LP filed Aug 14, 2026 Schedule 13G/A passive 0 shares issuer: Rallybio Corp filing 0%
  12. BLSMCormorant Asset Management, LP filed Aug 13, 2026 Schedule 13D may seek influence 959,090 shares issuer: BlossomHill Therapeutics, Inc. filing 3.13%